Turning Point Therapeutics, Inc. Marketable Securities
Turning Point Therapeutics, Inc. had Marketable Securities of $0 as of 2018-12-31, per its 10-K filed 2020-03-18.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2020-03-18
- 2018-12-31: Marketable Securities $0.00.
| Period end | Marketable Securities |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2020-03-18 |